| Name | Title | Contact Details |
|---|
MD is a Salem, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Inland Northwest Health Services is a Spokane, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medbox, Inc., a leader in the rapidly emerging cannabis sector, provides specialized services to operators of dispensaries, cultivation centers, manufacturers and research facilities in those states where approved. Through trusted clients and affiliates, the company promotes efficient, consistent, high quality products that are priced right, readily available and safely packaged.
Halyard Health, Inc. (Halyard) seeks to advance health and healthcare. The Company has two business segments: Surgical and Infection Prevention (S&IP) and Medical Devices. The Company`s S&IP business provides products that address the prevention of healthcare-acquired infections (HAIs) and provide protection for both healthcare workers and patients. Its S&IP product portfolio includes sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves. The Company`s Medical Devices business consists of a range of medical device solutions. Its portfolio includes post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems, and enteral feeding tubes. The Company sells its products in more than 100 countries.
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the iStent is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, the company completed an initial public offering and its shares are now traded on the New York Stock Exchange under the ticker symbol "GKOS". Founded in 1998, Glaukos is based in San Clemente, California.